Wojciech Wojakowski

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +6

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial

Michał Tendera, Wojciech Wojakowski, Witold Rużyłło et al. · European Heart Journal · 2009 · 469 citations · Full text

Life Sciences, Cardiology, Cell Biology +16

Mobilization of CD34/CXCR4 ⁺ , CD34/CD117 ⁺ , c-met ⁺ Stem Cells, and Mononuclear Cells Expressing Early Cardiac, Muscle, and Endothelial Markers Into Peripheral Blood in Patients With Acute Myocardial Infarction

Wojciech Wojakowski, Michał Tendera, Anna M. Michałowska et al. · Circulation · 2004 · 442 citations · Full text

Life Sciences, Cardiology, Cell Biology +17

Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood – preliminary report

Magda Kucia, Marcin Wysoczynski, Magdalena Baśkiewicz‐Masiuk et al. · Leukemia · 2006 · 374 citations

Life Sciences, Cell Biology, Molecular Biology +14

Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT–FFR trial

Elvin Kedhi, Balázs Berta, Tomasz Roleder et al. · European Heart Journal · 2021 · 282 citations · Full text

Medicine, Cardiology, Surgery +17